Division of Nephrology, Tufts Medical Center, Boston, MA.
Johns Hopkins Bloomberg School of Public Health, Baltimore, MD.
Am J Kidney Dis. 2019 Feb;73(2):206-217. doi: 10.1053/j.ajkd.2018.08.013. Epub 2018 Oct 19.
RATIONALE & OBJECTIVE: Chronic kidney disease (CKD) is complicated by abnormalities that reflect disruption in filtration, tubular, and endocrine functions of the kidney. Our aim was to explore the relationship of specific laboratory result abnormalities and hypertension with the estimated glomerular filtration rate (eGFR) and albuminuria CKD staging framework.
Cross-sectional individual participant-level analyses in a global consortium.
SETTING & STUDY POPULATIONS: 17 CKD and 38 general population and high-risk cohorts.
Cohorts in the CKD Prognosis Consortium with data for eGFR and albuminuria, as well as a measurement of hemoglobin, bicarbonate, phosphorus, parathyroid hormone, potassium, or calcium, or hypertension.
Data were obtained and analyzed between July 2015 and January 2018.
We modeled the association of eGFR and albuminuria with hemoglobin, bicarbonate, phosphorus, parathyroid hormone, potassium, and calcium values using linear regression and with hypertension and categorical definitions of each abnormality using logistic regression. Results were pooled using random-effects meta-analyses.
The CKD cohorts (n=254,666 participants) were 27% women and 10% black, with a mean age of 69 (SD, 12) years. The general population/high-risk cohorts (n=1,758,334) were 50% women and 2% black, with a mean age of 50 (16) years. There was a strong graded association between lower eGFR and all laboratory result abnormalities (ORs ranging from 3.27 [95% CI, 2.68-3.97] to 8.91 [95% CI, 7.22-10.99] comparing eGFRs of 15 to 29 with eGFRs of 45 to 59mL/min/1.73m), whereas albuminuria had equivocal or weak associations with abnormalities (ORs ranging from 0.77 [95% CI, 0.60-0.99] to 1.92 [95% CI, 1.65-2.24] comparing urinary albumin-creatinine ratio > 300 vs < 30mg/g).
Variations in study era, health care delivery system, typical diet, and laboratory assays.
Lower eGFR was strongly associated with higher odds of multiple laboratory result abnormalities. Knowledge of risk associations might help guide management in the heterogeneous group of patients with CKD.
慢性肾脏病(CKD)的并发症反映了肾脏滤过、肾小管和内分泌功能的紊乱。我们旨在探讨特定实验室结果异常和高血压与估计肾小球滤过率(eGFR)和白蛋白尿 CKD 分期框架的关系。
全球联盟的横断面个体参与者水平分析。
17 个 CKD 队列和 38 个一般人群和高危队列。
CKD 预后联盟中的队列,具有 eGFR 和白蛋白尿数据,以及血红蛋白、碳酸氢盐、磷、甲状旁腺激素、钾或钙的测量值,或高血压。
数据于 2015 年 7 月至 2018 年 1 月之间获取和分析。
我们使用线性回归模型研究 eGFR 和白蛋白尿与血红蛋白、碳酸氢盐、磷、甲状旁腺激素、钾和钙值之间的关联,以及使用 logistic 回归模型研究高血压和每种异常的分类定义之间的关联。使用随机效应荟萃分析对结果进行汇总。
CKD 队列(n=254666 名参与者)中 27%为女性,10%为黑人,平均年龄为 69(SD,12)岁。一般人群/高危队列(n=1758334 名参与者)中 50%为女性,2%为黑人,平均年龄为 50(16)岁。较低的 eGFR 与所有实验室结果异常呈强分级关联(OR 范围为 3.27[95%CI,2.68-3.97]至 8.91[95%CI,7.22-10.99],比较 eGFR 为 15 至 29 与 eGFR 为 45 至 59mL/min/1.73m),而白蛋白尿与异常的关联则不明确或较弱(OR 范围为 0.77[95%CI,0.60-0.99]至 1.92[95%CI,1.65-2.24],比较尿白蛋白-肌酐比值>300 与<30mg/g)。
研究时代、医疗保健系统、典型饮食和实验室检测的差异。
较低的 eGFR 与多种实验室结果异常的高几率强烈相关。对风险关联的了解可能有助于指导 CKD 异质患者的管理。